CSX Corporation logo CSX - CSX Corporation

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 27
HOLD 17
SELL 2
STRONG
SELL
0
| PRICE TARGET: $50.82 DETAILS
HIGH: $60.00
LOW: $32.00
MEDIAN: $53.00
CONSENSUS: $50.82
UPSIDE: 6.14%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 65% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Overvalued Strong
Trading 107.3% above fair value
Current Price $47.88
Bear Case $18.48 61.4% downside ($18.48 - $47.88) / $47.88 = -61.4% $1.54 × 12x P/E
Fair Value $23.10 51.8% downside ($23.10 - $47.88) / $47.88 = -51.8% $1.54 × 15x P/E
Bull Case $27.72 42.1% downside ($27.72 - $47.88) / $47.88 = -42.1% $1.54 × 18x P/E

Adjust Assumptions

15.0x
1.54$

Key Value Driver

Normalized P/E multiple (15x base case)

Implied Market Multiple 31.1x

Plain-Language Summary

Applying a 15x P/E to adjusted EPS of $1.54, the base-case value is $23.10 per share. DDM cross-check: $57.65.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (46 analysts) $50.82
Analyst Range $32.00 – $60.00
Divergence from AlphaVal 55%

Warnings

ℹ Dividend-based valuation: $57.65 (above our primary estimate by 150%). Large gaps may signal the dividend doesn't reflect full earning power.
ℹ Wall Street's average price target is $50.82 (from 46 analysts). Our estimate is 55% below the consensus -- consider that gap carefully.

Key Risks

  • Growth DCF inappropriate — terminal value assumptions dominate
  • EV/EBITDA misleading for regulated businesses where capex is mandated
  • Regulatory risk is a fat tail not visible in normal multiples